Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 04-2025 | 01-2025 | 10-2024 | 07-2024 | 04-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,693 | 40,297 | 47,735 | 52,371 | 57,156 |
| Receivables | 4,309 | 4,245 | 3,842 | 3,988 | 3,935 |
| Inventories | 5,714 | 5,987 | 6,391 | 6,832 | 7,324 |
| Other current assets | 0 | 0 | 0 | 5,000 | 0 |
| TOTAL | $48,278 | $52,217 | $59,661 | $70,031 | $75,736 |
| Non-Current Assets | |||||
| PPE Net | 12,380 | 12,303 | 12,495 | 12,367 | 12,638 |
| Other Non-Current Assets | 2,858 | 2,990 | 3,135 | 3,366 | 5,095 |
| TOTAL | $15,238 | $15,293 | $15,630 | $15,733 | $17,733 |
| Total Assets | $63,516 | $67,510 | $75,291 | $85,764 | $93,469 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 75 |
| Accounts payable and accrued liabilities | 1,395 | 672 | 1,269 | 1,376 | 1,520 |
| Accrued Expenses | 5,170 | 5,392 | 5,618 | 5,714 | 5,376 |
| Other current liabilities | 73 | 73 | 76 | 76 | N/A |
| TOTAL | $17,011 | $17,176 | $23,397 | $24,794 | $21,663 |
| Non-Current Liabilities | |||||
| Long Term Debt | 129 | 146 | 155 | 189 | 180 |
| Other Non-Current Liabilities | 2,978 | 3,572 | 4,081 | 4,669 | 2,595 |
| TOTAL | $3,107 | $3,718 | $4,236 | $4,858 | $2,775 |
| Total Liabilities | $20,118 | $20,894 | $27,633 | $29,652 | $24,438 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,403 | 52,403 | 52,244 | 52,244 | 51,458 |
| Common Shares | 523 | 523 | 521 | 521 | 511 |
| Retained earnings | -302,129 | -299,339 | -297,804 | -294,428 | -281,047 |
| Other shareholders' equity | 1,671 | 2,273 | 1,960 | 1,885 | 2,498 |
| TOTAL | $43,398 | $46,616 | $47,658 | $56,112 | $69,031 |
| Total Liabilities And Equity | $63,516 | $67,510 | $75,291 | $85,764 | $93,469 |